Cargando…
Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction
BACKGROUND: Sini Decoction (SND), a classic Chinese medicine prescription, has been proved to have a good effect on heart failure (HF), whereas its underlying mechanism is still unclear. In order to explore the therapeutic mechanism of SND, we combined with 16S rRNA gene sequencing to analyze the co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969309/ https://www.ncbi.nlm.nih.gov/pubmed/35354453 http://dx.doi.org/10.1186/s12906-022-03575-4 |
_version_ | 1784679219815514112 |
---|---|
author | Zhao, Zhenyu Liu, Jiahao Hu, Yanzhi Zhang, Xining Cao, Liqin Dong, Zhenhua Li, Lin Hu, Zhixi |
author_facet | Zhao, Zhenyu Liu, Jiahao Hu, Yanzhi Zhang, Xining Cao, Liqin Dong, Zhenhua Li, Lin Hu, Zhixi |
author_sort | Zhao, Zhenyu |
collection | PubMed |
description | BACKGROUND: Sini Decoction (SND), a classic Chinese medicine prescription, has been proved to have a good effect on heart failure (HF), whereas its underlying mechanism is still unclear. In order to explore the therapeutic mechanism of SND, we combined with 16S rRNA gene sequencing to analyze the composition of gut microflora in rats with HF. MATERIAL AND METHODS: Twenty Sprague–Dawley (SD) rats were divided into four groups (n = 5): normal group, model group, SND treatment group (SNT group), and metoprolol (Met) treatment group (Meto group). All the rats except the normal group were intraperitoneally injected with doxorubicin (concentration 2 mg/mL, dose 0.15 mL/100 g) once a week to induce HF. After successfully modeling, SND and Met were gavaged to rats, respectively. After the treatment period, blood was collected for hematological analyses, myocardial tissue and colon tissues were collected for Hematoxylin–Eosin (H&E) staining, and mucosal scrapings were collected for Illumina Miseq high-throughput sequencing. RESULTS: Echocardiographic results suggested that both left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS) in Model rats decreased compared with normal rats. The results of H&E staining showed that compared with the model group, the structures of myocardial tissue and colon tissue in the SNT group and Meto group showed a recovery trend. Alpha results showed that the model group had higher species diversity and richness compared with the normal group. After treatment, the richness and diversity of intestinal bacteria in the SNT group were significantly restored, and Met also showed the effect of adjusting bacterial diversity, but its effect on bacterial richness was not ideal. At the Family level, we found that the number of several bacteria associated with HF in the model group increased significantly. Excitingly, SND and Met had shown positive effects in restoring these HF-associated bacteria. Similarly, the results of Linear discriminant analysis (LDA) showed that both SND and Met could reduce the accumulation of bacteria in the model group caused by HF. CONCLUSION: Collectively, SND can improve HF by regulating the intestinal flora. This will provide new ideas for the clinical treatment of patients with HF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-022-03575-4. |
format | Online Article Text |
id | pubmed-8969309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89693092022-04-01 Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction Zhao, Zhenyu Liu, Jiahao Hu, Yanzhi Zhang, Xining Cao, Liqin Dong, Zhenhua Li, Lin Hu, Zhixi BMC Complement Med Ther Research BACKGROUND: Sini Decoction (SND), a classic Chinese medicine prescription, has been proved to have a good effect on heart failure (HF), whereas its underlying mechanism is still unclear. In order to explore the therapeutic mechanism of SND, we combined with 16S rRNA gene sequencing to analyze the composition of gut microflora in rats with HF. MATERIAL AND METHODS: Twenty Sprague–Dawley (SD) rats were divided into four groups (n = 5): normal group, model group, SND treatment group (SNT group), and metoprolol (Met) treatment group (Meto group). All the rats except the normal group were intraperitoneally injected with doxorubicin (concentration 2 mg/mL, dose 0.15 mL/100 g) once a week to induce HF. After successfully modeling, SND and Met were gavaged to rats, respectively. After the treatment period, blood was collected for hematological analyses, myocardial tissue and colon tissues were collected for Hematoxylin–Eosin (H&E) staining, and mucosal scrapings were collected for Illumina Miseq high-throughput sequencing. RESULTS: Echocardiographic results suggested that both left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS) in Model rats decreased compared with normal rats. The results of H&E staining showed that compared with the model group, the structures of myocardial tissue and colon tissue in the SNT group and Meto group showed a recovery trend. Alpha results showed that the model group had higher species diversity and richness compared with the normal group. After treatment, the richness and diversity of intestinal bacteria in the SNT group were significantly restored, and Met also showed the effect of adjusting bacterial diversity, but its effect on bacterial richness was not ideal. At the Family level, we found that the number of several bacteria associated with HF in the model group increased significantly. Excitingly, SND and Met had shown positive effects in restoring these HF-associated bacteria. Similarly, the results of Linear discriminant analysis (LDA) showed that both SND and Met could reduce the accumulation of bacteria in the model group caused by HF. CONCLUSION: Collectively, SND can improve HF by regulating the intestinal flora. This will provide new ideas for the clinical treatment of patients with HF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-022-03575-4. BioMed Central 2022-03-30 /pmc/articles/PMC8969309/ /pubmed/35354453 http://dx.doi.org/10.1186/s12906-022-03575-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhao, Zhenyu Liu, Jiahao Hu, Yanzhi Zhang, Xining Cao, Liqin Dong, Zhenhua Li, Lin Hu, Zhixi Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction |
title | Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction |
title_full | Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction |
title_fullStr | Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction |
title_full_unstemmed | Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction |
title_short | Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction |
title_sort | bacterial diversity in the intestinal mucosa of heart failure rats treated with sini decoction |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969309/ https://www.ncbi.nlm.nih.gov/pubmed/35354453 http://dx.doi.org/10.1186/s12906-022-03575-4 |
work_keys_str_mv | AT zhaozhenyu bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT liujiahao bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT huyanzhi bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT zhangxining bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT caoliqin bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT dongzhenhua bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT lilin bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction AT huzhixi bacterialdiversityintheintestinalmucosaofheartfailureratstreatedwithsinidecoction |